• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Diagnostics (Basel) . Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19

tetano

Editor, Senior Moderator
Diagnostics (Basel)


. 2021 Nov 12;11(11):2089.
doi: 10.3390/diagnostics11112089.
Urinary SARS-CoV-2 RNA Is an Indicator for the Progression and Prognosis of COVID-19

Lu Zhang[SUP] 1 [/SUP], Maoqing Tian[SUP] 1 [/SUP], Yuan Song[SUP] 1 [/SUP], Wei Liang[SUP] 1 [/SUP], Xiaogang Li[SUP] 2 [/SUP], Yongqing Tong[SUP] 3 [/SUP], Huiming Wang[SUP] 1 [/SUP]



Affiliations

Abstract

Background: We aimed to analyze clinical characteristics and find potential factors to predict poor prognosis in patients with coronavirus disease 2019 (COVID-19).
Methods: We analyzed the clinical characteristics and laboratory tests of COVID-19 patients and detected SARS-CoV-2 RNA in urine sediments collected from 53 COVID-19 patients enrolled in Renmin Hospital of Wuhan University from 31 January 2020 to 18 February 2020 with qRT-PCR analysis. Then, we classified those patients based on clinical conditions (severe or non-severe syndrome) and urinary SARS-CoV-2 RNA (U[SUB]RNA[/SUB][SUP]-[/SUP] or U[SUB]RNA[/SUB][SUP]+[/SUP]).
Results: We found that COVID-19 patients with severe syndrome (severe patients) showed significantly higher positive rate (11 of 23, 47.8%) of urinary SARS-CoV-2 RNA than non-severe patients (4 of 30, 13.3%, p = 0.006). U[SUB]RNA[/SUB][SUP]+[/SUP] patients or severe U[SUB]RNA[/SUB][SUP]+[/SUP] subgroup exhibited higher prevalence of inflammation and immune discord, cardiovascular diseases, liver damage and renal dysfunction, and higher risk of death than U[SUB]RNA[/SUB][SUP]-[/SUP] patients. To understand the potential mechanisms underlying the viral urine shedding, we performed renal histopathological analysis on postmortems of patients with COVID-19 and found severe renal vascular endothelium lesion characterized by an increase of the expression of thrombomodulin and von Willebrand factor, markers to assess the endothelium dysfunction. We proposed a theoretical and mathematic model to depict the potential factors that determine the urine shedding of SARS-CoV-2.
Conclusions: This study indicated that urinary SARS-CoV-2 RNA detected in urine specimens can be used to predict the progression and prognosis of COVID-19 severity.

Keywords: COVID-19; SARS-CoV-2; endothelium; indicator; renal pathology.
 
Back
Top Bottom